These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20166509)

  • 1. Two masters.
    Schneider CE
    Hastings Cent Rep; 2010; 40(1):9-10. PubMed ID: 20166509
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments in health law. Wyeth v. Levine: challenging implied pre-emption for drugs.
    Nair P
    J Law Med Ethics; 2009; 37(3):527-30. PubMed ID: 19791315
    [No Abstract]   [Full Text] [Related]  

  • 3. Good law from tragic facts--Congress, the FDA, and preemption.
    Annas GJ
    N Engl J Med; 2009 Sep; 361(12):1206-11. PubMed ID: 19759383
    [No Abstract]   [Full Text] [Related]  

  • 4. Wyeth v Levine: implications for public health policy and practice.
    David S; Rosenbaum S
    Public Health Rep; 2010; 125(3):494-7. PubMed ID: 20433045
    [No Abstract]   [Full Text] [Related]  

  • 5. Accidental intra-arterial injection of promethazine HCl during general anesthesia: report of a case.
    Mostafavi H; Samimi M
    Anesthesiology; 1971 Dec; 35(6):645-6. PubMed ID: 5124747
    [No Abstract]   [Full Text] [Related]  

  • 6. Warning signs.
    Nature; 2008 Mar; 452(7185):254. PubMed ID: 18354433
    [No Abstract]   [Full Text] [Related]  

  • 7. Injectable promethazine: gangrene.
    Prescrire Int; 2010 Oct; 19(109):216-7. PubMed ID: 21188805
    [No Abstract]   [Full Text] [Related]  

  • 8. The dangers of intravenous promethazine administration.
    Paparella S
    J Emerg Nurs; 2007 Feb; 33(1):53-6; quiz 92. PubMed ID: 17258055
    [No Abstract]   [Full Text] [Related]  

  • 9. Supreme Court rules Wyeth's Phenergan warnings were inadequate.
    Lavine G
    Am J Health Syst Pharm; 2009 Apr; 66(8):698, 700. PubMed ID: 19336826
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome with promethazine.
    Mendhekar DN; Andrade C
    Aust N Z J Psychiatry; 2005; 39(1-2):113-4. PubMed ID: 15660719
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment: Promethazine adverse events after implementation of a medication shortage interchange.
    Habib AS; Breen TW; Gan TJ
    Ann Pharmacother; 2005; 39(7-8):1370; author reply 1370-1. PubMed ID: 15956221
    [No Abstract]   [Full Text] [Related]  

  • 12. Accidental intra-arterial injection: a case report, new treatment modalities, and a review of the literature.
    Keene JR; Buckley KM; Small S; Geldzahler G
    J Oral Maxillofac Surg; 2006 Jun; 64(6):965-8. PubMed ID: 16713815
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceuticals and medical devices: cost savings.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-79. PubMed ID: 23297449
    [No Abstract]   [Full Text] [Related]  

  • 16. Catastrophic complications of intravenous promethazine.
    Paula R; Peckler B; Nguyen M; Orban D; Butler T
    Am J Emerg Med; 2010 May; 28(4):535.e1-4. PubMed ID: 20466253
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA user fee law poised for passage in Congress but not without stirring up controversy.
    Finkelstein J
    J Natl Cancer Inst; 2007 Jul; 99(14):1072-3. PubMed ID: 17623792
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 19. Premedication with promethazine and transdermal scopolamine reduces the incidence of nausea and vomiting after intrathecal morphine.
    Tarkkila P; Törn K; Tuominen M; Lindgren L
    Acta Anaesthesiol Scand; 1995 Oct; 39(7):983-6. PubMed ID: 8848904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: business practices. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.